3% Hypertonic Saline Administration in Subdural Hematoma
In patients with subdural hematoma requiring intracranial pressure reduction, administer 3% hypertonic saline as 100 mL boluses over 10 minutes, repeatable up to three times at 10-minute intervals, with a target sodium correction not exceeding 8 mmol/L in any 24-hour period. 1
Indications for 3% Hypertonic Saline in SDH
Use 3% hypertonic saline for:
- Elevated intracranial pressure (ICP) – Hypertonic saline effectively reduces ICP in traumatic brain injury including subdural hematoma, with evidence showing improved cerebral perfusion pressure and reduced duration of intracranial hypertension 1, 2
- Severe symptomatic hyponatremia (sodium <120 mmol/L with neurological symptoms such as altered mental status, seizures, or coma) – This requires immediate intervention regardless of the presence of SDH 1, 3, 4
- Impending herniation – Patients with signs of transtentorial herniation benefit from urgent hyperosmolar therapy 1, 5
Dosing Protocol
Bolus administration:
- Give 100 mL of 3% NaCl intravenously over 10 minutes 1, 3
- May repeat up to three times at 10-minute intervals for severe symptoms or refractory ICP elevation 1, 3
- For ICP management specifically, bolus doses of 250 mL have been used in studies, though 100 mL boluses provide more controlled correction 1
Continuous infusion (alternative approach):
- 3% hypertonic saline continuous infusion may be used for sustained ICP control, particularly in pediatric TBI or when prolonged management is anticipated 1
- Target serum sodium of 145-155 mmol/L has been used safely in some head injury protocols, though this represents controlled hypernatremia requiring careful monitoring 1, 3
Critical Correction Rate Limits
Never exceed 8 mmol/L sodium increase in any 24-hour period to prevent osmotic demyelination syndrome, even in acute settings 1, 3, 6, 7
For severe symptomatic hyponatremia concurrent with SDH:
- Initial target: 6 mmol/L increase over 6 hours or until severe symptoms resolve 3, 6, 4
- After initial 6 mmol/L correction, only 2 mmol/L additional correction is permitted in the remaining 18 hours to stay within the 8 mmol/L/24-hour limit 3, 6
High-risk patients require even slower correction (4-6 mmol/L per day maximum):
- Advanced liver disease 1, 3, 6, 7
- Chronic alcoholism 3, 6, 7
- Malnutrition 3, 6, 7
- Chronic hyponatremia (>48 hours duration) 3, 6, 7
Monitoring Requirements
Serum sodium monitoring:
- Every 2 hours during initial correction phase for severe symptomatic hyponatremia 3, 6, 4
- Every 4-6 hours after symptom resolution or for ongoing ICP management 1, 3, 6
- Re-check within 6 hours after each bolus to guide further therapy 1, 3
Clinical monitoring:
- Neurological examination – Glasgow Coma Scale, pupillary response, motor function 2, 4, 5
- ICP monitoring (if device in place) – Target ICP <20 mmHg 1, 2
- Cerebral perfusion pressure – Maintain CPP >60 mmHg 1, 8
Special Considerations in SDH
Surgical decompression patients:
- Higher doses of hypertonic saline (>8.0 mEq/kg sodium over 5 days) are associated with improved survival in surgically decompressed SDH patients (7.5% mortality vs 38.9% with lower doses) 2
- ≥1400 mEq total sodium administration correlates with better neurological outcomes at 3 months (76.9% following commands vs 50.0% with lower doses) 2
- Continue 3% saline infusion perioperatively when initiated prehospital or in emergency department 5
Combination with surgical evacuation:
- Hypertonic saline as bridge to surgery – Early preoperative administration improves cerebral perfusion pressure and may optimize conditions for surgical intervention 8
- Combined treatment (HTS + surgical evacuation) shows slightly better outcomes than surgery alone in animal models, though both are effective 8
Transition and Maintenance
After initial stabilization:
- Switch to isotonic maintenance fluids (0.9% NaCl) once severe symptoms resolve and sodium reaches 120-125 mmol/L 3, 4
- Avoid hypotonic solutions (0.45% saline, lactated Ringer's, D5W) as they can worsen cerebral edema 3, 4
- For sustained ICP control, may continue 3% infusion for 24-48 hours with intensive monitoring 2, 5
Management of Overcorrection
If sodium rises >8 mmol/L in 24 hours:
- Immediately discontinue hypertonic saline 3, 6, 7
- Administer D5W (5% dextrose in water) to lower sodium 3, 6, 7
- Consider desmopressin to slow or reverse rapid sodium rise 3, 6, 7
- Target: bring total 24-hour correction back to ≤8 mmol/L from baseline 3, 6
Hypernatremia Correction After Prolonged HTS Use
If iatrogenic hypernatremia develops from prolonged 3% saline therapy:
- Do not leave hypernatremia uncorrected – The brain adapts to elevated sodium within 48-72 hours, and failure to correct creates risk of rebound ICP elevation when therapy is discontinued 9
- Maximum correction rate: 10-15 mmol/L per 24 hours using hypotonic fluids (D5W or 0.45% NaCl) 9
- Target rate: 0.4 mmol/L/hour to prevent osmotic demyelination during correction 9
- Monitor sodium every 4-6 hours during correction phase 9
Common Pitfalls to Avoid
- Never use fluid restriction in SDH patients with hyponatremia – This can worsen cerebral perfusion and is contraindicated in neurosurgical patients at risk for vasospasm 1, 3, 4
- Never exceed 8 mmol/L correction in 24 hours – Osmotic demyelination syndrome can occur 2-7 days after rapid correction with devastating neurological consequences 3, 6, 7
- Never continue uncorrected hypernatremia after prolonged HTS therapy – Brain adaptation means rebound ICP elevation risk regardless of iatrogenic cause 9
- Never use lactated Ringer's or other hypotonic solutions in acute SDH management – These worsen cerebral edema 3, 4
- Never delay treatment while awaiting ADH or natriuretic peptide levels – These tests do not alter acute management and cause harmful delays 3, 4
Integration Across Care Continuum
Prehospital to hospital transition: